Arnulf Stenzl, MD

Articles by Arnulf Stenzl, MD

Dr. Stenzl on Future Research With Enzalutamide in Prostate Cancer

ByArnulf Stenzl, MD

July 22nd 2020

Arnulf Stenzl, MD, discusses future research efforts with enzalutamide in prostate cancer.

Dr. Stenzl on the Safety Profile of Enzalutamide/ADT in mHSPC

ByArnulf Stenzl, MD

July 13th 2020

Arnulf Stenzl, MD, discusses the safety profile of enzalutamide in combination with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.

Arnulf Stenzl, MD

Articles by Arnulf Stenzl, MD

Dr. Stenzl on Future Research With Enzalutamide in Prostate Cancer

Dr. Stenzl on the Safety Profile of Enzalutamide/ADT in mHSPC

Latest Updated Articles

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma

Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer

Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD

Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma